Suppr超能文献

可能用于治疗新冠肺炎患者的药物。

Drugs that Might Be Possibly Used for Treatment of COVID-19 Patients.

作者信息

Shihab Mehdi Salih, Hamah-Ameen Baram

机构信息

Pharmacy Department, Al- Esraa University College, 10001 Baghdad, Iraq.

Chemistry Department, College of Science, Al-Nahrain University, 10001 Baghdad, Iraq.

出版信息

Russ J Bioorg Chem. 2021;47(4):789-804. doi: 10.1134/S1068162021040130. Epub 2021 Aug 21.

Abstract

The drug development process for Coronavirus disease (COVID-19) is the research process to create a preventive vaccine or therapeutic prescription drug to relieve the severity of 2019-2020 (COVID-19). In different stages of preclinical or clinical research, several hundred special scientific research centers, research organizations, and health agencies have developed and tried enormous numbers of vaccine candidates and new drugs for COVID-19 disease. In order to identify new therapies against COVID-19, several clinical trials have been in progress worldwide.

摘要

冠状病毒病(COVID-19)的药物研发过程是开发预防性疫苗或治疗性处方药以减轻2019-2020年冠状病毒病(COVID-19)严重程度的研究过程。在临床前或临床研究的不同阶段,数百个专业科研中心、研究组织和卫生机构已经研发并试验了大量针对COVID-19疾病的候选疫苗和新药。为了确定针对COVID-19的新疗法,全球范围内正在进行多项临床试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9dc/8380022/2a3973dc5611/11171_2021_8341_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验